AggiornAmenti in riAnimAzione e terApiA intensivA - Pacini Editore

More documents

Recommendations

Info

38 Liver ischemia/reperfusion injury: processes in inflammatory networks--a review M. Abu-Amara S.Y. Yang N. Tapuria B. Fuller B. Davidson A. Seifalian Liver Transplantation and Hepatobiliary Unit, Royal Free Hospital, London, UK Liver ischemia/reperfusion (IR) injury is typified by an inflammatory response. Understanding the cellular and molecular events underpinning this inflammation is fundamental to developing therapeutic strategies. Great strides have been made in this respect recently. Liver IR involves a complex web of interactions between the various cellular and humoral contributors to the inflammatory response. Kupffer cells, CD4+ lymphocytes, neutrophils, and hepatocytes are central cellular players. Various cytokines, chemokines, and complement proteins form the communication system between the cellular components. The contribution of the danger-associated molecular patterns and pattern recognition receptors to the pathophysiology of liver IR injury are slowly being elucidated. Our knowledge on the role of mitochondria in generating reactive oxygen and nitrogen species, in contributing to ionic disturbances, and in initiating the mitochondrial permeability transition with subsequent cellular death in liver IR injury is continuously being expanded. Here, we discuss recent findings pertaining to the aforementioned factors of liver IR, and we highlight areas with gaps in our knowledge, necessitating further research. Liver Transpl 2010;16(9):1016-32
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation F. Piscaglia A. Gianstefani M. Ravaioli R. Golfieri A. Cappelli E. Giampalma E. Sagrini G. Imbriaco A.D. Pinna L. Bolondi Bologna Liver Transplant Group Division of Internal Medicine, Department of Digestive Disease and Internal Medicine, St. Orsola-Malpighi University Hospital, Bologna, Italy Malignant portal vein thrombosis is a contraindication for liver transplantation. Patients with cirrhosis and early hepatocellular carcinoma (HCC) may have either malignant or benign (fibrin clot) portal vein thrombosis. The aim of this study was to assess prospectively whether well-defined diagnostic criteria would enable the nature of portal vein thrombosis to be established in patients with HCC under consideration for liver transplantation. Benign portal vein thrombosis was diagnosed by the application of the following criteria: lack of vascularization of the thrombus on contrast-enhanced ultrasound and on computed tomography or magnetic resonance imaging, absence of mass-forming features of the thrombus, absence of disruption of the walls of veins, and, if uncertainty persisted, biopsy of the thrombus for histological examination. Patients who did not fulfill the criteria for benign thrombosis were not placed on the transplantation list. In this study, all patients evaluated at our center during 2001-2007 with a diagnosis of HCC in whom portal vein thrombosis was concurrently or subsequently diagnosed were discussed by a multidisciplinary group to determine their suitability for liver transplantation. The outcomes for 33 patients who met the entry criteria of the study were as follows: in 14 patients who were placed on the transplantation list and underwent liver transplantation, no malignant thrombosis was detected when liver explants were examined histologically; 5 patients who were placed on the transplantation list either remained on the list or died from causes unrelated to HCC; in 9 patients, liver transplantation was contraindicated on account of a strong suspicion, or confirmation, of the presence of malignant portal vein thrombosis; and 5 patients who were initially placed on the transplantation list were subsequently removed from it on account of progression of HCC in the absence of evidence of neoplastic involvement of thrombosis. In conclusion, for a patient with HCC and portal vein thrombosis, appropriate investigations can establish whether the thrombosis is benign; patients with HCC and benign portal vein thrombosis are candidates for liver transplantation. Liver Transpl 2010;16(5):658-67 39
Page 1 and 2: ARTI AggiornAmenti in riAnimAzione
Page 3 and 4: presentazione In questo numero di A
Page 5 and 6: Hypoalbuminemia and acute kidney in
Page 7 and 8: Beneficial effects of hyperoncotic
Page 9 and 10: prevalence of parental thrombophili
Page 11 and 12: ecipient tissue factor expression i
Page 13 and 14: Cost-effectiveness of strategies fo
Page 15 and 16: Quality of life after intensive car
Page 17 and 18: Cirrhotic patients in the medical i
Page 19 and 20: Fluids after cardiac surgery: a pil
Page 21 and 22: Bench-to-bedside review: targeting
Page 23 and 24: Cerebral microcirculation is impair
Page 25 and 26: microvascular dysfunction in the su
Page 27 and 28: Both passive leg raising and intrav
Page 29 and 30: monitoring the microcirculation in
Page 31 and 32: the rAge axis in systemic inflammat
Page 33 and 34: Use of recombinant factor viia in U
Page 35 and 36: the effect of acute traumatic brain
Page 37: inflammatory alterations in a novel
Page 41 and 42: Fresh-frozen plasma transfusion str
Page 43 and 44: ons formation under restrictive rep
Page 45 and 46: albunorm RIASSUnTO dELLE CARATTERIS
Page 47 and 48: Sistema-Organo-Classe Reazioni (fre

AggiornAmenti in riAnimAzione e terApiA intensivA - Pacini Editore

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?